Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on OYE3 Mut. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111454918A details a novel OYE3-Mut mutant for >99% ee (R)-citronellal, offering cost-effective biocatalytic solutions for flavor and pharma intermediates.